Remembering Joep Lange: A Legacy of HIV/AIDS Research and Global Health
"Honoring the life and work of a giant in HIV/AIDS research and care, who tragically lost his life alongside colleague Jacqueline van Tongeren."
The global health community mourned the tragic loss of Joep Lange and Jacqueline van Tongeren, who were among the passengers on Malaysian Airlines flight MH17. Their untimely deaths resonated deeply, particularly within the HIV/AIDS research and care community, where they had dedicated their lives to making a difference.
Joep Lange was a towering figure in HIV/AIDS research, known for his innovative thinking, unwavering dedication, and relentless pursuit of solutions. His work touched countless lives, and his legacy continues to inspire those working to combat the epidemic.
This article pays tribute to Joep Lange's remarkable contributions, highlighting his key achievements, his impact on global health initiatives, and his enduring commitment to ensuring access to quality HIV care and treatment for all.
Evidence Standards and HIV Services
WHO’s consolidated HIV guidelines were developed using the GRADE approach, expert consultation, and country experience. They aim to help countries deliver high-quality, person-centred HIV services, advance universal health coverage, and contribute to ending AIDS as a public health threat by 2030. Evidence-based decision-making is widely used in health policy and programs, but the HASTE article notes that randomized controlled trials with HIV endpoints, while encouraged, have limitations as the gold standard for public health interventions.
A Pioneer in HIV/AIDS Research
Joep Lange's contributions to HIV/AIDS research were extensive and transformative. He played a pivotal role in the development and testing of antiretroviral therapies, leading several landmark trials that revolutionized treatment strategies. His work helped to transform HIV from a death sentence into a manageable condition for many.
- Originator and co-principal investigator of pivotal trials on antiretroviral therapy (INCAS, 2NN).
- Pioneering work on the prevention of mother-to-child transmission of HIV (PETRA, SIMBA).
- Instrumental in establishing the ATHENA observational cohort in the Netherlands.
- Early advocate for HIV eradication strategies and pre-exposure prophylaxis (PrEP).
Tracking HIV Burden and Current Research
A 2024 study on the global, regional, and national burden of HIV/AIDS from 1990 to 2021 emphasizes the need to evaluate epidemiological trends and monitor progress toward reducing HIV incidence and mortality. The Lancet source describes GBD 2019’s assessment of sex-specific HIV burden and its use of metrics including the incidence-to-mortality and incidence-to-prevalence ratios to evaluate progress toward global targets. Nature’s HIV infections research page lists an immune-correlates analysis of CD4+ T-cell responses to mRNA-1273 SARS-CoV-2 vaccination in people with HIV, part of the multicenter CoVPN 3008 observational study.
Persistent Gaps in the HIV Response
WHO reports that failure to suppress HIV infection remains a serious problem among children, aggravated by a lack of child-friendly formulations of the newest and most effective antiretroviral drugs designed for adults. At the same time, WHO reports that since 2010 new HIV infections fell by 39% and HIV-related deaths fell by 51%, with more than 14 million lives saved through antiretroviral therapy over that period. A 2024 review describes HIV/AIDS as a global public health crisis and examines its political, economic, and social impacts.
An Enduring Legacy of Compassion and Action
Joep Lange's impact extended far beyond his scientific achievements. He was a compassionate and caring physician, a tireless advocate for those living with HIV, and a mentor to countless students and researchers. He embodied the spirit of innovation, collaboration, and unwavering commitment to social justice.
Uncertainty and Emerging Research Directions
A study of global, regional, and national HIV/AIDS disease burden describes epidemiological uncertainties about the epidemic’s future. A 2025 research overview reports that scientists are investigating novel treatments, testing vaccine candidates, and exploring possible cures, which it characterizes as areas of renewed urgency. A UNAIDS meeting report states that from 1990 to 2024, new infections declined by 40% and AIDS-related deaths by 54%.
Integrating HIV Care with Health Systems
A 2026 article describes the global HIV response, particularly prevention, as having long been characterized by exceptionalism. It says HIV initiatives have often operated vertically, separately from broader health systems, with parallel delivery, monitoring, evaluation, and governance structures influenced and driven by vertical funding. Another article presents HIV/AIDS as a major global health challenge and reviews response strategies intended to reduce its impact and ultimately eradicate it.
His work with the PharmAccess Foundation, Health Insurance Fund and other spin offs, made great strides to improve healthcare in Africa, by providing means, sustainable systems, and encouragement.
The loss of Joep Lange and Jacqueline van Tongeren serves as a reminder of the importance of continuing their work towards a world free from HIV/AIDS and characterized by equality, tolerance, and access to quality healthcare for all. Their legacy will continue to inspire generations of researchers, clinicians, and advocates to strive for a healthier and more just world.